Background:Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm characterized by the unregulated production of mature granulocytes and the BCR/ABL fusion gene presence. The age of presentation is between 45 to 55 years, however up to 30% of patients will be 60 years or over at diagnosis. It has been evidenced that the five-year survival rate is 80% greater with the development of Tyrosine Kinase Inhibitors (TKIs).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.